Cynthia Yee is a Partner at Vensana Capital. Cynthia brings nearly two decades of investing, operating, and public equities experience to Vensana. Prior to joining Vensana, she served as a Principal at Windham Venture Partners, where she led the firm’s investments in multiple companies, including Cartiva Medical (acquired), ClarVista Medical (acquired), Personal Genome Diagnostics (acquired) and NeuSpera Medical.  She was previously an investor at NEA working across its medtech and healthcare services practices, and she spent time in business development and strategic marketing at Epix Therapeutics and medtech incubator D3DC. Cynthia began her career in public equities, covering medical devices at Piper Jaffray and biotechnology at Pacific Growth Equities. Cynthia currently serves on the board of directors of Evident Vascular and SpyGlass Pharma. She graduated from the University of California, Berkeley with a BA in Integrative Biology and a BS in Business Administration at the Haas School of Business.